Power Law company profile

Ultimovacs

Biotech & Life Sciences · Oslo, Norway · Founded 2011 · IPO 2019 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$35M

Market cap · 2026

Investors

1 investor on Ultimovacs's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 1 investor entered at this stage

Global footprint

Web traffic by country

330 monthly visits
across markets

🇺🇸 United States60.6%

🇬🇧 United Kingdom30.3%

Top 2 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo